Hyperuricemia as a Ninth Upstream Gate in the Selenoprotein Axis: Uric Acid-Mediated NRF2 Suppression, RAGE-NF-κB Hepcidin Amplification, and Ferroptosis-Driven Hyperuricemic Nephropathy as Three Convergent Mechanisms Connecting Gout to the Selenoprotein Axis Framework

This paper proposes that hyperuricemia represents a ninth upstream gate in the Selenoprotein Axis operating through three simultaneous and non-redundant mechanisms: (1) uric acid-mediated NRF2 suppression reducing GPx4 expression and enabling ferroptosis in renal proximal tubular cells; (2) RAGE-NF-kB activation by urate crystals elevating IL-6 and hepcidin, tightening the convergent triad iron-inflammation loop; and (3) direct ferroptosis induction in tubular cells through RAGE signaling and iron-dependent lipid peroxidation, documented in a March 2025 publication in Antioxidants and Redox Signaling. Soluble uric acid accounts for up to 55% of extracellular free radical neutralization capacity — the pathological state is crystal-form urate specifically. Combined urate-lowering therapy with selenoprotein axis optimization represents a mechanistically complete renal protection strategy for gout patients that current guidelines do not address. All claims are hypothesis-level requiring prospective clinical confirmation.